MARC Record from marc_columbia

LEADER: 02132fam a2200349 a 4500
001 4053310
005 20221027024956.0
008 960214t19961996enka b 001 0 eng c
010 $a 96007005
020 $a0471960071 (acid-free paper)
035 $a(OCoLC)34282287
035 $a(OCoLC)ocm34282287
035 $9AMA3056HS
035 $a(NNC)4053310
035 $a4053310
040 $aDNLM/DLC$cDLC$dDLC$dOrLoB-B
050 10 $aRC271.I45$bI464 1996
060 10 $aQZ 266 I3477 1996
082 00 $a616.99/406$220
245 00 $aImmunotherapy in cancer /$cedited by Martin Gore and Pamela Riches.
260 $aChichester ;$aNew York :$bJohn Wiley & Sons,$c[1996], ©1996.
300 $ax, 291 pages :$billustrations ;$c24 cm
336 $atext$btxt$2rdacontent
337 $aunmediated$bn$2rdamedia
504 $aIncludes bibliographical references and index.
505 00 $g1.$tThe History of Immunotherapy /$rM. Gore and P. Riches --$g2.$tInterferons /$rS. D. Fossa --$g3.$tInterferon-beta and Interferon-gamma in Cancer Therapy /$rS. T. A. Malik --$g4.$tInterleukin-2 /$rJ. Atzpodien, A. Schomburg and J. Buer --$g5.$tTumour Necrosis Factor /$rC. Boshoff and A. L. Jones --$g6.$tRecently Available Cytokines in Early Clinical Trials (IL1, IL3, IL4, IL6, IL12) /$rT. Eisen --$g7.$tHaemopoietic Growth Factors /$rH. Wagner, S. Rassan and D. Linch --$g8.$tTumour Vaccines /$rR. Vile, B. Souberbielle and A. G. Dalgleish --$g9.$tThe Role of Monoclonal Antibodies in the Management of Cancer /$rH. Linardou and A. A. Epenetos --$g10.$tGene Therapy /$rP. M. Patel and M. K. L. Collins --$g11.$tAdoptive Immunotherapy /$rJ. A. Bridgewater --$g12.$tPractical Aspects of Delivering Cytokines /$rJ. Moore.
650 0 $aCancer$xImmunotherapy.$0http://id.loc.gov/authorities/subjects/sh87002642
650 12 $aNeoplasms$xtherapy.$0https://id.nlm.nih.gov/mesh/D009369Q000628
650 12 $aImmunotherapy.$0https://id.nlm.nih.gov/mesh/D007167
700 1 $aGore, Martin.$0http://id.loc.gov/authorities/names/n96800534
700 1 $aRiches, Pamela.$0http://id.loc.gov/authorities/names/n96800535
852 00 $boff,hsl$hRC271.I45$iI464 1996